Key Metrics
30.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
20 - 25
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
125
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Pharmacology
- Q1 Cancer Research
- Q1 Infectious Diseases
- Q1 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
3.67
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
40%
4 to 6 months
42%
7 to 9 months
17%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Clinical evidence
- Ovarian cancer
- Immunotherapy
- Glioblastoma
- Bacterial persistence
- Antitumor immunity
- Drug resistance
- Homologous recombination
- Prostate cancer
- Paclitaxel
- Autophagy
- Tumor microenvironment
- Drug response
- High-grade serous carcinoma
- Enterococcus
- Tumor immunity
- Homologous Recombination Deficiency
- Docetaxel
- Vancomycin resistance
- Immune checkpoint inhibitors
Journal Specifications
| Overview | |
| Publisher | CHURCHILL LIVINGSTONE |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1998 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Drug Resistance Updates ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4
- 1 Jan 25
- Drug Resistance Updates
-
Full paper
Global phylogeography and antibiotic resistance characteristics of Morganella: An epidemiological, spatial, comparative genomic study
- 1 Jan 25
- Drug Resistance Updates
-
Full paper
Reshaping the Battlefield: A Decade of Clonal Wars Among Staphylococcus aureus in China
- 1 Jan 25
- Drug Resistance Updates
-
Full paper
Association of idealized amphiphiles and protease inhibitors: conferring antimicrobial peptides with stable antibacterial activity under physiological conditions to combat multidrug-resistant bacteria
- 1 Dec 24
- Drug Resistance Updates
-
Full paper
CEA-Induced PI3K/AKT Pathway Activation through the Binding of CEA to KRT1 Contributes to Oxaliplatin Resistance in Gastric Cancer
- 1 Dec 24
- Drug Resistance Updates
-
Full paper
Editorial on “Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling”
- 1 Dec 24
- Drug Resistance Updates
Scite analysis
Powered by scite_
1k articles received 49.3k citations see all
- 904 Supporting
- 47,384 Mentioning
- 79 Contrasting
Editorial notices
- 0 Retractions
- 1 Withdrawals
- 0 Corrections
- 4 Errata
- 0 Expression of Concern
FAQs
How long has Drug Resistance Updates been actively publishing?
Drug Resistance Updates has been in operation since 1998 till date.
What is the publishing frequency of Drug Resistance Updates ?
Drug Resistance Updates published with a Bi-monthly frequency.
How many articles did Drug Resistance Updates publish last years ?
In 2023, Drug Resistance Updates published 98 articles.
What is the eISSN & pISSN for Drug Resistance Updates ?
For Drug Resistance Updates,eISSN is 1532-2084 and pISSN is1368-7646.
What is Citescore for Drug Resistance Updates ?
Citescore for Drug Resistance Updates is 30.8.
What is H index for Drug Resistance Updates ?
H index for Drug Resistance Updates is 125.
What is SNIP score for Drug Resistance Updates ?
SNIP score for Drug Resistance Updates is 3.67.
What is the SJR for Drug Resistance Updates ?
SJR for Drug Resistance Updates is Q1.
Who is the publisher of Drug Resistance Updates ?
CHURCHILL LIVINGSTONE is the publisher of Drug Resistance Updates.